Research
Sell
A Sell rating means lf0 research identifies a meaningful gap between a companys current valuation and its underlying fundamentals, typically driven by decelerating growth, margin pressure, balance-sheet risk, or a competitive position eroding faster than the market has priced in. Sell-rated companies carry a risk/reward skew that favors caution over the timeframe of the analysis.




The Scorecard: 1 Month Update: NXE Sell — Correct so far
Revisiting our Sell call on NXE: entry $10.40, latest $9.19, -11.6%.
DigitalOcean Stock Analysis: Buy or Sell? Valuation & Cash Flow
DigitalOcean Holdings Inc. (DOCN) is rated Sell as its rich valuation is backed by growth, not durable cash conversion. Revenue is rising, but levered free…
Astera Labs Stock Analysis: Buy or Sell? Valuation & AI Growth
Astera Labs (ALAB) earns a Sell rating as its premium valuation already prices in a long AI infrastructure ramp. Revenue is growing fast, but customer…
The Scorecard: 1 Month Update: SPHR Sell — Correct so far
Revisiting our Sell call on SPHR: entry $147.34, latest $141.13, -4.2%.
The Scorecard: 2 Month Update: AMKR Sell — Correct so far
Revisiting our Sell call on AMKR: entry $60.60, latest $53.61, -11.5%.
Ichor Stock Analysis: Buy or Sell? Valuation, FCF Yield & Margins
Ichor Holdings (ICHR) is rated sell because the recovery is real, but valuation already reflects it. TTM free cash flow yield is just 0.5%, and…
The Scorecard: 1 Month Update: ALT Sell — Correct so far
Revisiting our Sell call on ALT: entry $3.15, latest $3.06, -2.9%.
The Scorecard: 2 Month Update: NLST Sell — Incorrect so far
Revisiting our Sell call on NLST: entry $2.44, latest $5.58, +128.7%.
Cameco Stock Analysis: Buy or Sell? Valuation, FCF & Leverage
Cameco (CCJ) is rated a sell because its valuation is rich while free cash flow remains thin. The balance sheet is strong, but the stock…
The Scorecard: 1 Month Update: LHX Sell — Correct so far
Revisiting our Sell call on LHX: entry $260.92, latest $238.04, -8.8%.
Most Popular Research